Hiro Shimada

2.3k total citations · 1 hit paper
14 papers, 1.7k citations indexed

About

Hiro Shimada is a scholar working on Neurology, Genetics and Cancer Research. According to data from OpenAlex, Hiro Shimada has authored 14 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Neurology, 4 papers in Genetics and 4 papers in Cancer Research. Recurrent topics in Hiro Shimada's work include Neuroblastoma Research and Treatments (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Hiro Shimada is often cited by papers focused on Neuroblastoma Research and Treatments (6 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Hiro Shimada collaborates with scholars based in United States, Switzerland and Japan. Hiro Shimada's co-authors include John M. Maris, Katherine K. Matthay, Judith G. Villablanca, C. Patrick Reynolds, Susan L. Cohn, M. Fevzi Özkaynak, Paul M. Sondel, S. D. Gillies, Helen X. Chen and Alice L. Yu and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Hiro Shimada

14 papers receiving 1.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

2010 1.2k citations Alice L. Yu, Andrew L. Gilman et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiro Shimada United States	8	1.0k	689	542	370	306	14	1.7k
Gian Paolo Tonini Italy	25	1.1k 1.0×	947 1.4×	337 0.6×	523 1.4×	130 0.4×	88	1.8k
Friedrich Feuerhake Germany	21	401 0.4×	433 0.6×	395 0.7×	204 0.6×	215 0.7×	89	1.6k
KyungMann Kim United States	15	336 0.3×	308 0.4×	552 1.0×	129 0.3×	309 1.0×	22	1.1k
Iacopo Petrini Italy	27	504 0.5×	884 1.3×	1.0k 1.9×	688 1.9×	193 0.6×	91	2.5k
Fabian Model Switzerland	16	283 0.3×	1.1k 1.7×	832 1.5×	653 1.8×	369 1.2×	42	2.6k
Kristian W. Pajtler Germany	24	555 0.5×	1.2k 1.7×	284 0.5×	371 1.0×	99 0.3×	91	2.2k
Bing Liao China	22	252 0.2×	670 1.0×	371 0.7×	444 1.2×	135 0.4×	71	1.9k
Claudia Döring Germany	28	169 0.2×	1.1k 1.6×	712 1.3×	686 1.9×	461 1.5×	82	2.3k
Catherine Richon France	18	131 0.1×	608 0.9×	391 0.7×	419 1.1×	243 0.8×	32	1.2k
Amy E. McKee United States	24	195 0.2×	686 1.0×	1.3k 2.5×	339 0.9×	370 1.2×	37	2.3k

Countries citing papers authored by Hiro Shimada

Since Specialization

Citations

This map shows the geographic impact of Hiro Shimada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiro Shimada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiro Shimada more than expected).

Fields of papers citing papers by Hiro Shimada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiro Shimada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiro Shimada. The network helps show where Hiro Shimada may publish in the future.

Co-authorship network of co-authors of Hiro Shimada

This figure shows the co-authorship network connecting the top 25 collaborators of Hiro Shimada. A scholar is included among the top collaborators of Hiro Shimada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiro Shimada. Hiro Shimada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Villablanca, Judith G., Samuel L. Volchenboum, Min H. Kang, et al.. (2016). A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma. Pediatric Blood & Cancer. 63(8). 1349–1356. 72 indexed citations

Li, Jingbo, Yun C. Chang, Chunhua Wu, et al.. (2016). The 14-3-3 Gene Function of Cryptococcus neoformans Is Required for its Growth and Virulence. Journal of Microbiology and Biotechnology. 26(5). 918–927. 7 indexed citations

Yanik, Gregory A., Judith G. Villablanca, John M. Maris, et al.. (2015). 131I-Metaiodobenzylguanidine with Intensive Chemotherapy and Autologous Stem Cell Transplantation for High-Risk Neuroblastoma. A New Approaches to Neuroblastoma Therapy (NANT) Phase II Study. Biology of Blood and Marrow Transplantation. 21(4). 673–681. 63 indexed citations

Yu, Alice L., Andrew L. Gilman, M. Fevzi Özkaynak, et al.. (2010). Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma. New England Journal of Medicine. 363(14). 1324–1334. 1233 indexed citations breakdown →

Ghugre, Nilesh R., Ignacio González-Gómez, Hiro Shimada, Thomas D. Coates, & John C. Wood. (2010). Quantitative analysis and modelling of hepatic iron stores using stereology and spatial statistics. Journal of Microscopy. 238(3). 265–274. 17 indexed citations

Douglas, Dorothea, Jessie Hao-Ru Hsu, Long Hung, et al.. (2008). BMI-1 Promotes Ewing Sarcoma Tumorigenicity Independent of CDKN2A Repression. Cancer Research. 68(16). 6507–6515. 109 indexed citations

Gürcan, Metin N., Tony Pan, Hiro Shimada, & Joel Saltz. (2006). Image Analysis for Neuroblastoma Classification: Segmentation of Cell Nuclei. PubMed. 2006. 4844–7. 79 indexed citations

Wood, John C., Maya Otto‐Duessel, Ignacio Ferreira González, et al.. (2006). Deferasirox and deferiprone remove cardiac iron in the iron-overloaded gerbil. Translational research. 148(5). 272–280. 63 indexed citations

Gürcan, Metin N., Tony Pan, Hiro Shimada, & Joel Saltz. (2006). Image Analysis for Neuroblastoma Classification: Segmentation of Cell Nuclei. Conference proceedings. 7 indexed citations

10.

Wood, John C., Maya Otto‐Duessel, Michelle Aguilar, et al.. (2005). ICL670 Removes Cardiac Iron in a Gerbil Model of Iron Overload.. Blood. 106(11). 2695–2695. 6 indexed citations

11.

Villablanca, Judith G., R C Seeger, Hiro Shimada, et al.. (2005). Outcome of high risk (HR) stage 3 neuroblastoma (NB) with myeloablative therapy and 13-cis-retinoic Acid. Journal of Clinical Oncology. 23(16_suppl). 8503–8503. 3 indexed citations

12.

Shaul, Donald B., Hui Xie, Hiro Shimada, B.E. Hardy, & Kathryn D. Anderson. (1999). Venous ischemia as a cause of ureteral necrosis in transplanted ureters. Journal of Pediatric Surgery. 34(11). 1725–1727. 14 indexed citations

13.

Shimada, Hiro & Atsuko Nakagawa. (1999). Tumors of the neuroblastoma group. International Journal of Clinical Oncology. 4(3). 123–132. 2 indexed citations

14.

Hoshino, Tyuji, et al.. (1989). [Prognostic significance of histopathological classification in patients with carcinoma of the uterine cervix].. PubMed. 41(5). 519–24. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact